Cargando…
Novel targeted agents for gastric cancer
Contemporary advancements have had little impact on the treatment of gastric cancer (GC), the world’s second highest cause of cancer death. Agents targeting human epidermal growth factor receptor mediated pathways have been a common topic of contemporary cancer research, including monoclonal antibod...
Autores principales: | Liu, Lian, Wu, Ning, Li, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411478/ https://www.ncbi.nlm.nih.gov/pubmed/22709792 http://dx.doi.org/10.1186/1756-8722-5-31 |
Ejemplares similares
-
Current Molecular Targeted Agents for Advanced Gastric Cancer
por: Nie, Shanshan, et al.
Publicado: (2020) -
Ion channels or aquaporins as novel molecular targets in gastric cancer
por: Xia, Jianling, et al.
Publicado: (2017) -
Targeted and novel therapy in advanced gastric cancer
por: Selim, Julie H., et al.
Publicado: (2019) -
Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy
por: Cidon, Esther Una, et al.
Publicado: (2013) -
Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
por: Poniewierska-Baran, Agata, et al.
Publicado: (2022)